Librela for Dogs: Does It Work, Side Effects, and the FDA Safety Signals
By Sarah Bennett · Last updated June 2, 2026 · 13 min read
This article is for information only. We are not veterinarians, and Librela is a prescription drug given by a vet. Use this to ask better questions at your appointment, not to replace your vet's judgment.
Librela for dogs is a once-monthly injection that controls the pain of canine osteoarthritis. Its generic name is bedinvetmab, it is made by Zoetis, and in May 2023 it became the first monoclonal antibody the FDA ever approved for use in dogs. For a lot of senior dogs with stiff, painful joints, it has been genuinely life-changing. It has also drawn an FDA safety notice and a stack of adverse-event reports that most product pages skip over. Both of those things are true at once, and a senior dog owner deserves the full picture before deciding.
This guide covers what Librela is, whether it works, the side effects and the FDA signals, which dogs should not get it, what it costs, and how to weigh it against the alternatives.
What Is Librela for Dogs?
Librela for dogs is an anti-nerve-growth-factor monoclonal antibody. That is a mouthful, so here is the plain version: it is a lab-made antibody that mops up a pain-signaling protein before the signal reaches your dog's brain.
| Detail | Librela (bedinvetmab) |
|---|---|
| Drug class | Anti-NGF monoclonal antibody |
| Maker | Zoetis |
| FDA approval (US) | May 5, 2023 (first canine monoclonal antibody approved) |
| How it is given | Subcutaneous injection, once a month, by a veterinary professional |
| Dose | 0.5 mg/kg (0.23 mg/lb), matched to one of five vial strengths (5, 10, 15, 20, 30 mg) |
| What it treats | Pain from osteoarthritis |
| Disease-modifying? | No. It controls pain; it does not rebuild the joint |
Because it is an antibody rather than a pill processed by the liver and kidneys, it does not carry the same organ-strain profile as long-term oral NSAIDs. That is the main reason vets reach for it in older dogs whose bloodwork makes daily NSAIDs harder to justify.
How Librela Works
Nerve growth factor (NGF) helps build the nervous system in puppies. In an adult dog, NGF does something different: levels rise in arthritic joints and amplify chronic pain. Bedinvetmab binds NGF and takes it out of circulation, so fewer pain signals travel up to the brain.
The trade-off is built into the mechanism. Pain is also a warning system. When you turn the volume down on a senior dog's joint pain, the dog may move more freely than the joint can actually handle, which is why vets advise easing activity up gradually rather than letting a newly comfortable dog overdo it.
Does Librela for Dogs Actually Work?
For most dogs, yes, with realistic expectations. The evidence is solid but not miraculous.
| Study | What it compared | Result |
|---|---|---|
| ~100 dogs with OA | Librela vs. meloxicam (an NSAID) | No significant difference in pain relief |
| 32 dogs with hip/stifle OA | Librela vs. Galliprant | At least as effective as Galliprant |
So Librela works about as well as the standard oral options, not dramatically better. Its real advantage is the once-a-month dosing and the gentler organ profile, not a higher ceiling on pain relief.
How long does Librela take to work? Some dogs improve within 7 days of the first injection. Others need up to 6 weeks, which is two weeks after the second monthly dose. If a dog has shown nothing by the third injection, the guidance is to stop and recheck the diagnosis rather than keep injecting. The manufacturer also reports that 1 to 10 dogs per 10,000 treated develop a lack of effect over time.
Librela Side Effects and the FDA Safety Signals
This is the part most pages gloss over, and it is the part a senior dog owner most needs.
Librela side effects fall into two very different buckets. Here is the honest split.
| Common, milder reports | Serious signals behind the FDA letter |
|---|---|
| Injection-site skin reactions | Neurological signs: ataxia (wobbliness), seizures, paresis, recumbency |
| Urinary tract infections | Just under 6,000 adverse-event reports (May 2023 to June 2024) |
| Increased thirst and urination, sometimes incontinence | At least 825 death reports, including euthanasia, in that window |
| Vomiting or diarrhea | Rapidly progressive osteoarthritis (see below) |
| A rise in blood urea nitrogen | These prompted the FDA's December 2024 Dear Veterinarian Letter |
In December 2024 the FDA issued that Dear Veterinarian Letter to vets after post-marketing surveillance turned up the neurological and musculoskeletal patterns in the right-hand column.
A separate concern is rapidly progressive osteoarthritis (RPOA). Atypical, fast joint deterioration was reported in some treated dogs starting in late 2024, and a May 2025 case series described 19 dogs with dramatic worsening, including bony overgrowth and dislocation. Most of those dogs were also on NSAIDs at the time. The mechanism is not yet understood.
Two things have to be held together here. First, these are voluntary adverse-event reports. A report does not prove the drug caused the outcome, and the count has to be read against the very large number of doses given since 2023. Second, the FDA does not send this kind of letter for nothing, and the neurological signals are consistent enough that the agency, the manufacturer, and independent vets all now flag them. The honest summary: Librela helps many dogs and is not being recalled, and the safety questions are real and still being studied. You and your vet are making a risk-benefit call, not following a settled answer.
You can report any suspected reaction to the FDA at 1-888-FDA-VETS or to Zoetis directly.
Which Dogs Should Not Get Librela
Some of these are firm rules; others are "discuss carefully with your vet."
| Verdict | Which dogs, and why |
|---|---|
| Do not use | Dogs under 12 months (under 18 months for some giant breeds); pregnant, nursing, or breeding dogs including males; any dog with a prior hypersensitivity reaction |
| Caution, discuss first | Neurological disease (intervertebral disc disease, degenerative myelopathy, lumbosacral stenosis), which was not studied and is where worsening-nerve reports cluster; dogs on a daily NSAID, given the RPOA reports; unstable joints, a torn cruciate, or recent surgery, none of which were in the studies |
If your senior dog has any history of a wobbly gait, dragging a paw, or a diagnosed back or spinal-cord problem, that history is exactly what your vet needs to hear before the first injection.
How Much Does Librela Cost?
Librela cost is driven by your dog's weight, because the dose, and the vial used, scale with body size. Reported 2025 to 2026 figures, which you should confirm with your own clinic:
| Dog size | Reported per-injection cost |
|---|---|
| Small (around 20 lb) | About $60 |
| Large (around 80 lb) | Up to about $150 |
With the exam and any bloodwork added in, a monthly visit often lands somewhere in the $90 to $220 range, and giant breeds at the top of the dosing scale can run higher. Some clinics fold the office visit into the injection price while others bill it separately (commonly $45 to $65), so ask how yours itemizes it. Urban and specialty hospitals tend to charge more than rural or suburban clinics. There is no at-home version, so every dose is a vet visit.
Librela vs NSAIDs and Other Arthritis Options
Librela is one tool, not the only one. Here is how it sits next to the main alternatives for senior dog arthritis.
| Option | What it is | Best when |
|---|---|---|
| Librela (bedinvetmab) | Monthly anti-NGF injection | Daily pills are hard, or bloodwork makes long-term NSAIDs risky |
| NSAIDs (carprofen, meloxicam, Galliprant, others) | Daily oral anti-inflammatory pain relief | First-line for many dogs; six are FDA-approved for dogs |
| Adequan | Injectable, the only FDA-approved disease-modifying OA drug (1997) | You want to target the joint itself, not just mask pain |
| Joint supplements | Glucosamine, chondroitin, omega-3, green-lipped mussel | Early or mild changes, or alongside other treatment |
In head-to-head studies Librela matched the NSAIDs on pain relief rather than beating them, so for a dog who tolerates a daily NSAID well and has clean bloodwork, there is no automatic reason to switch. The case for Librela is strongest when pilling is a daily battle or when liver and kidney values make a daily NSAID a harder call. Our home arthritis guide and joint supplement comparison cover the non-prescription side of the plan.
How to Decide With Your Vet
Librela is a conversation, not a default. Worth raising at the appointment:
- Is the diagnosis solid? Anti-NGF drugs are for osteoarthritis pain. If the real problem is a disc or a spinal-cord disease, Librela is the wrong tool and may be the risky one.
- What is my dog's neurological history? Any wobble, weakness, or diagnosed back problem changes the risk-benefit math.
- What else is my dog on? Flag every current medication, especially NSAIDs.
- What is the plan if it does not help by the third injection? A clear stop-and-reassess point prevents months of paying for a drug that is not working.
- What should I watch for at home? Ask which signs mean "call us" and keep an eye out in the first weeks.
A pre-treatment bloodwork baseline and a recheck after starting are both reasonable. So is increasing your dog's activity gradually once she feels better, so a suddenly comfortable senior does not reinjure a joint the first good week.
Librela for Senior Dogs: Our Honest Take
We have not used Librela. Our dog Lucy is a 7-year-old Border Collie without arthritis yet, so this is research, not personal experience, and we have said so throughout.
What we would do in a senior dog's shoes: treat Librela as a strong option, not a first move or a last resort. For an older dog who cannot take NSAIDs and is genuinely struggling to stand and walk, the monthly injection can return real quality of life, and the gentler organ profile matters at that age. We would want a clean neurological history first, we would not pair it with a daily NSAID, and we would hold the vet to a clear "is this working?" checkpoint by the third dose. The FDA signals would not scare us off a drug a vet recommends for the right dog, but they are exactly why we would not push for it casually either.
Frequently Asked Questions
Does Librela really work for dogs? For most dogs with osteoarthritis, yes. In studies it relieved pain about as well as meloxicam and at least as well as Galliprant. Some dogs improve within a week; others take up to six weeks. Not every dog responds, and if there is no improvement by the third monthly injection, the diagnosis should be rechecked.
What are the side effects of Librela for dogs? Commonly reported side effects include injection-site reactions, urinary tract infections, increased thirst and urination, and digestive upset. More serious reported signals, behind a December 2024 FDA letter, include neurological signs such as wobbliness, seizures, and weakness, and reports of rapidly worsening arthritis. These are adverse-event reports, which do not by themselves prove cause.
Why did the FDA warn about Librela? In December 2024 the FDA notified veterinarians about neurological and musculoskeletal adverse events reported during post-marketing surveillance, after nearly 6,000 reports and at least 825 death reports between the 2023 launch and mid-2024. Librela was not recalled; the letter was a heads-up so vets and owners could make informed decisions.
How long does Librela take to work? As soon as 7 days after the first injection for some dogs, and up to 6 weeks, meaning two weeks after the second dose, for others.
How much does Librela cost? Pricing scales with your dog's weight. Reported figures run from around $60 per injection for a small dog to about $150 for a large dog, with a typical monthly visit landing in the $90 to $220 range once an exam is included. Confirm current pricing with your clinic.
Can Librela be given with other pain medications? This is a vet decision. Because of the rapidly-progressive-arthritis reports, current guidance leans toward not running Librela alongside a daily NSAID long-term, and using a different medication for short pain flares.
Is Librela safe for senior dogs? For many senior dogs it provides real relief with a gentler organ profile than daily NSAIDs, which is why vets often consider it for older dogs. It is not the right choice for a dog with neurological disease, and the FDA safety signals make it a careful, vet-guided decision rather than a routine one.
Sources
- U.S. FDA: Dear Veterinarian Letter: adverse events reported in dogs treated with Librela (bedinvetmab), December 2024 (fda.gov)
- U.S. FDA: Librela (bedinvetmab) Freedom of Information Summary, approval date and dosing (animaldrugsatfda.fda.gov)
- American Veterinary Medical Association: FDA: Adverse events in dogs reported with monoclonal antibody drug (avma.org)
- Canine Arthritis Resources and Education: Librela: what we know and don't know (caninearthritis.org)
- American Kennel Club: Librela for Dogs: Uses, Side Effects, and Alternatives (akc.org)
- Zoetis: Librela dosing chart (zoetisus.com)
- Frontiers in Veterinary Science (2025): musculoskeletal adverse events in dogs receiving bedinvetmab
Keep Reading
- How to Help an Old Dog With Arthritis at Home
- Best Joint Supplements for Senior Dogs
- Best Orthopedic Dog Beds for Senior & Large Dogs
About the authors
Senior Dog Daily is written by Sarah Bennett and Leo Bennett, a husband-and-wife team in the American Midwest. We started researching senior dog care because of Lucy, our Border Collie. Neither of us is a veterinarian. What we do is read the primary sources, including FDA documents, manufacturer labels, and veterinary literature, and turn them into plain-language guides, with every medical claim traceable to a named source above. For anything involving Librela for dogs, or any prescription drug, your veterinarian's judgment about your individual dog always comes first.